Twist Bioscience (TWST) Change in Account Payables (2017 - 2026)

Twist Bioscience has disclosed Change in Account Payables across 10 years of filings, most recently posting $69000.0 for Q1 2026.

• In Q1 2026, Change in Account Payables fell 90.3% year-over-year to $69000.0; the TTM figure through Mar 2026 stood at $4.5 million (up 1201.46% YoY), while the FY2025 annual figure was $9.3 million, up 179.05% from the prior year.
• Change in Account Payables retreated to $69000.0 in Q1 2026, from $1.5 million in the prior quarter.
• Over the last five years, Change in Account Payables for TWST reached as high as $6.9 million in Q3 2022 and fell as low as -$7.5 million in Q1 2023.
• The 5-year median for Change in Account Payables is $69000.0 (2026), against an average of $232235.3.
• Annual changes were most pronounced in 2022 — Change in Account Payables jumped 65740.0% — and 2023, when it tumbled 889.83%.
• A 5-year view of Change in Account Payables shows it stood at $3.3 million in 2022, then sank by 228.12% to -$4.2 million in 2023, then jumped by 235.81% to $5.7 million in 2024, then plunged by 74.23% to $1.5 million in 2025, then slumped by 95.31% to $69000.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $69000.0, $1.5 million, and -$284000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.